August 13, 2025 · Form 4 insider transaction
Ho Carole sold 806 shares of DENALI THERAPEUTICS INC at $14.64 per share, a transaction worth $11.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted December 11, 2024.; Includes 128,405 Unvested RSUs.